Clinical Trials Directory

Trials / Completed

CompletedNCT00671502

A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back

Randomized, Double-Blind, Double-Dummy Trial of Two Sustained Release Formulations of Carisoprodol Compared to Placebo in Subjects With Acute, Painful, Musculoskeletal Spasm of the Lower Back

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
840 (actual)
Sponsor
Meda Pharmaceuticals · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.

Detailed description

Methodology: This was a randomized, double-blind, double-dummy, placebo-controlled, parallel-group study in subjects 18-70 years of age with acute, painful, muscle spasm of the lower back. The study consisted of a baseline screening (Study Day 1), during which subjects were evaluated for inclusion/exclusion criteria, and a 7-day double-blind treatment period (Study Day 1 through Study Day 7). Subjects were randomly assigned to be dosed twice daily with one of the following double-blind treatments: sustained release(SR) carisoprodol 500-mg tablets,sustained release (SR) carisoprodol 700-mg tablets, or placebo. Subjects were evaluated in the clinic on Study Days 1, 3 and 7. Subjects who remained symptomatic on Study Day 7 were allowed to continue in the study for a 7-day, double-blind extension period at the discretion of the Investigator. Subjects were contacted by telephone for a safety follow-up 7 days after the last dose of study medication. A pharmacokinetic (PK) substudy was conducted at selected sites. These sites obtained blood samples for PK analysis at the end of the 7-day treatment period and the 14-day treatment period, if applicable.

Conditions

Interventions

TypeNameDescription
DRUGCarisoprodol SR700 mg twice daily
DRUGCarisoprodol SR500 mg twice daily
DRUGPlaceboPlacebo tablet

Timeline

Start date
2008-04-01
Primary completion
2009-02-01
Completion
2009-02-01
First posted
2008-05-05
Last updated
2011-11-09
Results posted
2011-11-09

Locations

68 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00671502. Inclusion in this directory is not an endorsement.